Modern total shoulder arthroplasty seeks to produce a construct that reproduces the kinematics and stability of the native glenohumeral joint. The latest 4th generation implants are modular, adaptable, and capable of use as either anatomic or reverse shoulder arthroplasty components. During surgery, these implants are “universal”; post-operatively, they are “convertible”. Recent work has demonstrated that reverse shoulder arthroplasty components may indeed be the emerging standard of care for most (if not all) shoulder arthroplasty indications. As this new frontier develops, the use of a convertible/universal implant creates the flexibility to individually choose the best surgical option for each patient.
Reverse total shoulder arthroplasty (TSA) has demonstrated success in restoring active elevation for patients with rotator cuff dysfunction (with or without arthritis). However, recovery of active external rotation after reverse TSA has demonstrated variable success. Transfer of the latissimus dorsi has shown promise in restoring active external rotation in those patients with profound external rotation deficits. The combined latissimus transfer and reverse TSA procedure is intra-operatively challenging and fraught with post-operative complications. Technical details and precise indications are necessary to produce the best chance of success with this operation.
Stemless shoulder arthroplasty implants for the proximal humerus provide cementless metaphyseal prosthetic fixation. A near-perfect anatomic restoration of the proximal humeral articular surface is possible with this canal-sparing design—avoiding the risks associated with humeral stems and preserving bone for later revision. When compared with proximal humeral resurfacing, stemless arthroplasty avoids the potential technical errors that may lead to oversized implants, abnormal shift of the glenohumeral joint center of rotation, and excessive strain on the native rotator cuff. While canal-sparing stemless implants represent a new concept in shoulder arthroplasty without mid- and long-term results, the failures associated with resurfacing humeral arthroplasty have been documented in the literature. Unlike a stemless component, use of a resurfacing technique (and hence preservation of the humeral head) makes glenoid prosthetic implantation challenging and often impossible.
While the definition of “stiffness” after shoulder arthroplasty remains controversial, loss of range of motion in the post-arthroplasty setting can be a disabling functional complication. Fortunately, the incidence of post-operative loss of both active and passive range of motion is relatively less common following shoulder replacement procedures. Certain pre-operative diagnoses (proximal humeral fracture, capsulorraphy arthropathy, revision arthroplasty) are associated with post-operative soft tissue contractures. Certain medical comorbidities (diabetes, inflammatory arthropathy) are associated with periarticular capsular adhesions at the intracellular level. Management of the “stiff” shoulder arthroplasty must account for several confounding variables:
Appropriateness of diagnosis leading to arthroplasty Humeral and glenoid implants (size, version, hemi vs TSA vs RSA) Bone variables (fracture, bone loss/erosion) Soft tissue variables (rotator cuff, glenohumeral capsule) Patient comorbidities Techniques for management include soft tissue contracture release (manipulation, arthroscopic, open) and component revision.
The classic Hill-Sachs lesion is a compression or impression fracture of the humeral head in occurrence with anterior glenohumeral instability. The true incidence is unknown but clearly increases with recurrent instability episodes. Recent peer-reviewed literature has highlighted the importance of addressing “significant” humeral and glenoid bone defects in the management of glenohumeral instability. Quantification of the “significance” of a Hill-Sachs lesion with regard to location, size, and depth in relation to the glenoid has helped guide indications for surgical management. Options for managing Hill-Sachs lesions include both humeral-sided techniques (soft tissue, bone, and/or prosthetic techniques) and also glenoid-sided techniques (bone transfers to increase glenoid width). The majority of significant acute or chronic Hill-Sachs lesions can be effectively managed without prosthetic replacement. Is a prosthetic surface replacement ever indicated for the management of Hill-Sachs lesions? The peer-reviewed literature is sparse with the outcomes of this treatment, and significant consideration must be given to both the age of the patient and the need for such management when other effective non-prosthetic options exist. In a patient with more than half of the humeral head involved after instability episodes (perhaps seizure or polytrauma patients), metallic surface replacement arthroplasty may be an option that could require less involved post-operative care while restoring range of motion and stability.
High functional aspirations and an active ageing population equate to a growing number of patients awaiting hip arthroplasty demanding superior biomechanical function. The purpose of this study was to compare the biomechanics of top walking speed between two commonly used hip arthroplasty procedures to determine if a performance advantage existed. A retrospective comparative study was performed using sixty-seven subjects, twenty-two subjects in both hip resurfacing and total hip arthroplasty groups along with twenty-three healthy controls. All arthroplasty subjects were recruited based on high psychometric scoring and had been performed through a posterior approach, and had been discharged from follow-up. On an instrumented treadmill each subject was measured by a researcher blinded to which procedure that patient had undergone. After a six minute acclimatization period, the speed was increased incrementally until top walking performance had been attained. At all increments, ground reaction forces and temporospatial measurements were collected.Background
Methods
To investigate (1) The relationship between macroscopic grading and durability of cartilage repair following collagen-covered autologous chondrocyte implantation (ACI-C) in the knee; (2) The influence of histology on durability of cartilage repair; (3) The relationship between macroscopic appearance and histology of repair tissue. The modified Cincinnati scores (MCRS) of eighty-six patients were evaluated prospectively at one year and at the latest follow-up (mean follow-up = 4.7yrs. Range = 4 to 7 years). Needle biopsies of their cartilage repair site were stained with Haematoxylin and Eosin and some with Safranin O and the neo-cartilage was graded as hyaline-like (n=32, 37.2%), mixed fibro-hyaline (n=19, 22%) and fibro-cartilagenous tissue (n=35, 40.7%). Macroscopic grading of the repair tissue using the international cartilage repair society grading system (ICRS) was available for fifty-six patients in the study cohort. Statistical analyses were performed to investigate the significance of histology and ICRS grading on MCRS at 1 year and at the latest follow-up.Aims
Patients and methods
We report on minimum 2 year follow-up results of 71 patients randomised to autologous chondrocyte implantation (ACI) using porcine-derived collagen membrane as a cover (ACI-C) and matrix-induced autologous chondrocyte implantation (MACI) for the treatment of osteochondral defects of the knee. ACI is used widely as a treatment for symptomatic chondral and osteochondral defects of the knee. Variations of the original periosteum-cover technique include the use of porcine-derived type I/type III collagen as a cover (ACI-C) and matrix-induced autologous chondrocyte implantation (MACI) using a collagen bilayer seeded with chondrocytes.Purpose
Introduction
1) observational study to analyse surgeon’s and anaesthetist’s attitude to transfusion 2) prospective study to analyse the influence of perioperative haemoglobin concentration (Hb) on post-operative fatigue, hand grip strength, duration of in-patient physiotherapy and post-operative morbidity score (POMS) and also the prognostic factors to predict functional recovery.
200 patients (88 THR, 99 TKR, 13 hip resurfacing) were evaluated. Blood Hb, hand grip strength and vigour scores using fatigue questionnaire were estimated both preoperatively and at 3 days following surgery. POMS and the required duration of in-patient physiotherapy were also noted. The protocol for blood transfusion was for those with Hb less than 8 g/dL and/or post-operative symptoms attributable to anaemia.
A greater fall in postoperative Hb correlated significantly with a greater reduction in post-operative vigour score (p=0.02). Also a greater fall in vigour score was found to correlate significantly with the duration of in-patient physiotherapy (p<
0.001). A reduction in Hb of >
4g/dL from the pre-operative Hb predicted a significantly higher reduction in vigour score (p=0.03). A weak correlation was seen between a fall in Hb and POMS (p=0.09). A higher pre-operative Hb did not reduce the required duration of in-patient physiotherapy (p=0.72). There was no correlation between post-operative Hb and POMS (p=0.21) or duration of in-patient physiotherapy (p=0.20). A higher pre-operative grip strength predicted an early date of discharge by the physiotherapists (p=0.02).
The mean clinical follow-up was 39.4 months (13mths to 8 years) and the mean timing of biopsy was 14.8 months. The mean age at the time of surgery was 32 years (15 to 55 years). The site of defect was as follows: medial femoral condyle-95, lateral femoral condyle-25, trochlea-7, patella 27 and multiple sites- 12. The mean proportion of viable cells available for implantation was 96.3 % (range: 86 to 100) and the mean number of multiplication of cells during culture was 90 (range: 9 to 667).
The most favourable sites were lateral femoral condyle and trochlea where as the least favourable site was patella. There was no correlation between the mental score of patients and the final clinical result. Improvement in functional score was significantly higher among those who had a higher pre-operative function (p<
0.001). There were 7 patients who had previously failed micro-fracture and all of them obtained significant improvements in pain and function. Those who had a higher proportion of viable cells after cell culture demonstrated a tendency towards better outcome, but failed to reach statistical significance (p=0.14). There was no correlation between the number of cell multiplications at the time of cell culture and final clinical outcome (p=0.65). There was no significant difference in clinical outcome between the ACI- C and MACI techniques of ACI (p>
0.05).
the influence of histology on durability of cartilage repair following collagen-covered autologous chon-drocyte implantation (ACI-C) in the knee. the relationship between macroscopic grading and durability of cartilage repair; and the relationship between macroscopic appearance and histology of repair tissue.
There was no correlation between the ICRS grading and MCRS either at one year (p=0.12) or at the latest follow-up (p=0.16). Also, the ICRS grading of the repair tissue did not correlate with its histological type (p=0.12).
A higher pre-operative Hb did not reduce the required duration of in-patient physiotherapy (p=0.72). There was no correlation between post-operative Hb and POMS (p=0.21) or required duration of in-patient physiotherapy (p=0.20). A higher pre-operative grip strength predicted an early date of discharge by the physiotherapists (p=0.02).
The modified Cincinnati scores (MCRS) of eighty-six patients were evaluated prospectively at one year and at the latest follow-up following ACI-C (mean follow-up= 4.7 years. Range= 4 to 7 years). All these patients underwent biopsies of their cartilage repair site performed at variable periods between six months and five years following ACI-C (mean=22.2 months). The neo-cartilage was graded as hyaline (n=32), mixed fibrohyaline (n=19), fibrocartilagenous (n=35) and fibrous (n=0).
However, their clinical scores at the latest follow-up demonstrated a significantly superior result for those with hyaline repair tissue when compared to those with mixed fibro-hyaline and fibro-cartilagenous repair tissue (p=0.05). The percentage of patients with excellent and good results for those with hyaline, mixed fibro-hyaline and fibro-cartilagenous repair was 75, 42 and 68.6 respectively. Their mean MCRS were 70.6, 56.8 and 63.9 respectively.
Functional evaluations using the Harris hip scoring system and the delayed Trendelenberg test were performed on fifty randomly selected patients who had undergone cemented primary CPT total hip replacements (Zimmer UK) at least 12 months previously using Hardinge approach. The prosthesis used increases offset with femoral stem diameter but did not allow separate correction of neck offset. Patients were grouped according to whether hip offset had been accurately reconstructed, increased or decreased. Their functional outcomes were compared. There was no significant difference (p value 0.57) in the final functional outcome between the three groups. Reconstruction of the hip using a standard cemented CPT prosthesis produced considerable variation in the reconstructed hip arthroplasty offset. This resulted in no functionally significant effect. Accurate reconstruction of the hip joint offset in total hip arthroplasty may therefore not be as important in the early functional outcome as recently advocated.